-
admin
Posts
Intelligent Bio Solutions Announces Adoption of its Non-Invasive Drug Screening Solution by Global Engineering Leader, Pyrotek
Transition will Minimize Downtime, Deliver Faster, More Cost-Effective Results, and Improve Overall Safety and Productivity NEW YORK, Oct. 14, 2024 (GLOBE NEWSWIRE) — Intelligent Bio...
NewGenIvf Receives Nasdaq Notification Regarding Minimum Bid Price
BANGKOK, Oct. 14, 2024 (GLOBE NEWSWIRE) — NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), today announced that on October 8, 2024, the Company...
Sharps Technology, Inc. Announces Stockholders’ Approval of Reverse Stock Split Ratio and Effective Date
NEW YORK, Oct. 14, 2024 (GLOBE NEWSWIRE) — Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented,...
Integra LifeSciences to Host Third Quarter 2024 Financial Results Conference Call on November 4, 2024
PRINCETON, N.J., Oct. 14, 2024 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2024 financial results...
HeartFlow to Present Latest Data on AI-Enabled Coronary Artery Disease Management at TCT 2024
Long-term outcomes data from ADVANCE-DK Registry with HeartFlow FFRCT and Plaque Analysis and ongoing clinical studies highlighting CCTA and FFRCT diagnostic pathway to be discussed...
Canton Fair Launches New Mobile App to Enhance Attendee Experience Ahead of 136th Edition
GUANGZHOU, China, Oct. 14, 2024 /PRNewswire/ — Canton Fair has unveiled a new mobile app designed to enhance the convenience and efficiency of the event. This...
US FDA issues Study May Proceed letter for the Pilot Study of Pidnarulex Pharmacodynamics in Patients with Advanced Solid Tumors, Sponsored by the US National Cancer Institute
TAIPEI and SAN DIEGO, Oct. 14, 2024 /PRNewswire/ — Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare...
Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development
S-HiConTM is designed to maximize drug delivery and stability through high-concentration formulation The platform can address challenges associated with viscosity and achieve stable liquid formulation...
SurplusGLOBAL Accelerates Innovation in Semiconductor Equipment and Parts Ecosystem with AI… Appoints Dr. Benjamin Jeong as Chief AI Officer
SEOUL, South Korea, Oct. 14, 2024 /PRNewswire/ — SurplusGLOBAL, a platform company specializing in semiconductor equipment and parts, is accelerating innovation in the semiconductor distribution...
Inaugural Rector Designate announced for the Deakin University Lancaster University Indonesia campus
BANDUNG, Indonesia, Oct. 14, 2024 /PRNewswire/ — Professor Greg Barton, one of Australia’s leading scholars in Indonesian culture and politics, has been announced as the...
